Tivic Health Systems (NASDAQ:TIVC) Shares Down 0.5% – Should You Sell?

Shares of Tivic Health Systems, Inc. (NASDAQ:TIVC) were down 0.5% during trading on Monday . The stock traded as low as $0.7217 and last traded at $0.8457. Approximately 2,033,377 shares were traded during trading, an increase of 4,844% from the average daily volume of 41,131 shares. The stock had previously closed at $0.8503.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tivic Health Systems in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

Tivic Health Systems Trading Down 0.5%

The stock’s 50-day moving average is $1.07 and its 200-day moving average is $2.01. The stock has a market cap of $1.50 million, a price-to-earnings ratio of -0.13 and a beta of 2.01.

Hedge Funds Weigh In On Tivic Health Systems

An institutional investor recently bought a new position in Tivic Health Systems stock. Marex Group plc purchased a new position in shares of Tivic Health Systems, Inc. (NASDAQ:TIVC) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 39,283 shares of the company’s stock, valued at approximately $163,000. Marex Group plc owned 3.64% of Tivic Health Systems at the end of the most recent quarter. 4.25% of the stock is currently owned by institutional investors.

About Tivic Health Systems

Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company’s solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.

The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use.